Article

Alberta Breakthrough Pain Assessment Tool

The ABPAT is a standardized assessment "designed to characterize various clinically relevant elements of breakthrough pain" and support "improved research on the tolerability, safety and efficacy of novel breakthrough analgesic interventions."

The ABPAT is a standardized assessment “designed to characterize various clinically relevant elements of breakthrough pain” and support “improved research on the tolerability, safety and efficacy of novel breakthrough analgesic interventions.” Use the ABPAT to assess the degree to which your patients suffer from breakthrough pain and whether they are eligible for breakthrough pain studies.

Click here to view this third party resource.

Related Videos
Achieving Complete Renal Response and Reducing Corticosteroid Use in Lupus Nephritis Treatment With Obinutuzmab, with Richard Furie, MD
Identifying B-cell Depleting Agents for Lupus Nephritis, with Richard Furie, MD
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
© 2025 MJH Life Sciences

All rights reserved.